Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist representation of cash flow with a dollar sign and circular shape.

May 25, 2026

CLVT: Free Cash Flow May Offset AI And Portfolio Execution Risks

Analysts have adjusted their price targets for Clarivate, reflecting concerns about potential disruptions from AI and uncertainties surrounding its planned sale of the Life Sciences and Healthcare unit. Despite these challenges, there are indications of strong free cash flow and optimistic growth projections.Recent evaluations of Clarivate reveal a cautious outlook, with price targets now ranging between $2.40 and $6. Analysts have maintained their ratings but expressed a more conservative view
A blood sample in a test tube on a lab bench with reagents in the background.

May 25, 2026

In-Vitro Diagnostics Market to Reach US$131.68 Billion by 2032

The global In-Vitro Diagnostics (IVD) market is projected to grow from US$84.90 billion in 2024 to US$131.68 billion by 2032, driven by increasing demand across various medical fields including oncology, cardiology, and infectious diseases.This growth reflects a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032, as healthcare systems increasingly rely on accurate and scalable diagnostic testing. The market encompasses a diverse range of products, including instruments, reagents, and s
A minimalist illustration of a genetic strand and therapy vial on a dark background.

May 25, 2026

A Look At Krystal Biotech (KRYS) Valuation After UK Approval And Exclusivity Win For VYJUVEK

Krystal Biotech (KRYS) has gained attention following the UK's approval of VYJUVEK, a groundbreaking genetic therapy for dystrophic epidermolysis bullosa, which comes with orphan drug status and a potential 12-year exclusivity period.Currently valued at approximately $8.8 billion, Krystal Biotech's stock price has seen a recent decline, yet it boasts a notable 30-day return of nearly 10% and an impressive annual return of 139.46% due to VYJUVEK's approvals across various markets. Analysts are no
A biopsy needle and tissue sample in a clinical lab setting

May 25, 2026

Korean oncology firms head to ASCO with clinical data, AI biomarker studies

Korean oncology firms are gearing up for the American Society of Clinical Oncology (ASCO) meeting, showcasing a diverse range of clinical data and AI biomarker studies aimed at enhancing their global presence in oncology.Scheduled for May 29 to June 2, 2026, in Chicago, ASCO 2026 will host a variety of stakeholders, including oncologists and investors. Korean companies plan to present findings across several cancer types, including immuno-oncology and targeted therapies, reflecting a shift towar
A vial of KEYTRUDA in a clinical setting

May 25, 2026

Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment

Merck is advancing its cancer treatment offerings in Europe with a significant recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for KEYTRUDA (pembrolizumab) in combination with Padcev (enfortumab vedotin-ejfv) for bladder cancer.This recommendation targets adults with resectable muscle-invasive bladder cancer (MIBC) who are not eligible for cisplatin-based chemotherapy. The proposed use includes neoadjuvant therapy and continued treatment
A minimalist representation of a smart otoscope for pediatric healthcare.

May 24, 2026

EarSmartAI: Pre-Seed Investment To Advance AI-Powered Pediatric Ear Infection Diagnostics

EarSmartAI has secured a $250,000 pre-seed investment from Boomerang Ventures to enhance its AI-driven diagnostic platform for pediatric ear infections. This funding comes as the company aims to meet the rising demand for efficient pediatric healthcare solutions.Located in Indianapolis, EarSmartAI is developing a connected care platform that allows parents to evaluate potential ear infections at home. Utilizing a smart otoscope, proprietary AI algorithms, and a mobile app, the platform targets t
A small-molecule drug compound on a lab bench in a biopharmaceutical lab

May 24, 2026

Redwood AI’s Data Boom and Defense Push Contrast With Silent Pharma Pact

Redwood AI is making strides in both the defense and pharmaceutical sectors, yet its stock remains volatile due to a lack of financial clarity.The Canadian AI company has recently announced a partnership with Resilience Biosciences, a biopharmaceutical firm focused on developing non-opioid therapies. This collaboration will utilize Redwood’s advanced software for designing small-molecule drug candidates. However, the absence of financial specifics in the announcement has left investors uncertain
A petri dish containing a sputum sample in a dimly lit laboratory setting.

May 24, 2026

India strengthening TB detection through AI, digital diagnostics: JP Nadda

India is leveraging AI and digital diagnostics to enhance tuberculosis (TB) detection, as highlighted by Union Health Minister JP Nadda during a recent event at the World Health Assembly.The Minister emphasized the crucial role of timely screening and equitable access to healthcare in building resilient health systems. He articulated that improving lung health screening transcends technology; it is fundamentally about saving lives and reducing the burden of disease on individuals and families. U
Flat illustration of a DNA strand and AI assistant icon

May 24, 2026

Assessing Qiagen (NYSE:QGEN) Valuation After New AI Assistant Launch And Expanded NVIDIA Collaboration

Qiagen has recently intensified its focus on artificial intelligence with the launch of the QIA Agent digital assistant and an expanded partnership with NVIDIA aimed at enhancing bioinformatics and drug discovery processes.Despite these advancements and a proposed increase in dividends, Qiagen's stock performance remains mixed. The share price has seen a slight uptick recently but is down approximately 26% year-to-date, raising questions about the company's long-term growth potential. Analysts s
Flat design of a medical imaging device

May 24, 2026

Siemens Healthineers Wins FDA Nod for AI Imaging Suite as Diagnostics Crisis and Spin-Off Plan Domin

Siemens Healthineers has received FDA approvals for its AI imaging technology, but faces challenges in its diagnostics division.Siemens Healthineers recently achieved six regulatory approvals for its Artis interventional imaging portfolio, marking a significant advancement for its Optiq AI imaging chain, which enhances image quality using deep learning. However, this positive development contrasts sharply with the ongoing struggles in its diagnostics unit, which experienced a 6.5% revenue declin
Flat illustration of a drug compound in minimalist design

May 23, 2026

Did Thermo Fisher’s AI-Focused Investor Day and Clario Deal Just Redefine TMO’s Investment Narrative?

Thermo Fisher Scientific's recent Investor Day and its acquisition of Clario signal a strategic pivot towards AI integration and enhanced service offerings in the life sciences sector.The company's announcement included a quarterly dividend of $0.47 per share and emphasized its commitment to AI-driven clinical and laboratory solutions. This move aims to strengthen its position within the pharmaceutical and biotech industries, particularly through enhanced drug development capabilities and expand
A tissue sample on a microscope slide in a laboratory setting.

May 23, 2026

Halsa Global Accelerates Life Sciences Transformation with AI-Ready Salesforce Life Sciences Cloud Migration and Modernization Services

Halsa Global is enhancing the transformation of life sciences by introducing a comprehensive migration framework tailored for Salesforce Life Sciences Cloud, aimed at modernizing operations in the pharmaceutical, biotech, and medtech sectors.Recently, Halsa Global, recognized as a Salesforce Summit Partner, announced advancements in its migration and modernization services for the Salesforce Life Sciences Cloud. This initiative is designed to assist organizations in the life sciences sector tran